世界の薬物・遺伝子送達システム市場インサイト及び予測(~2026年)

【英語タイトル】Global Drug and Gene Delivery Systems Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(QYR20NV11714)・商品コード:QYR20NV11714
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:92
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは薬物・遺伝子送達システムの世界市場について調査・分析した資料です。種類別(ドラッグデリバリーシステム、遺伝子デリバリーシステム)の市場規模、用途別(感染症、腫瘍、眼科、泌尿器科、糖尿病、中枢神経系)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別薬物・遺伝子送達システムの競争状況、市場シェア
・世界の薬物・遺伝子送達システム市場:種類別市場規模 2015年-2020年(ドラッグデリバリーシステム、遺伝子デリバリーシステム)
・世界の薬物・遺伝子送達システム市場:種類別市場規模予測 2021年-2026年(ドラッグデリバリーシステム、遺伝子デリバリーシステム)
・世界の薬物・遺伝子送達システム市場:用途別市場規模 2015年-2020年(感染症、腫瘍、眼科、泌尿器科、糖尿病、中枢神経系)
・世界の薬物・遺伝子送達システム市場:用途別市場規模予測 2021年-2026年(感染症、腫瘍、眼科、泌尿器科、糖尿病、中枢神経系)
・北米の薬物・遺伝子送達システム市場分析:米国、カナダ
・ヨーロッパの薬物・遺伝子送達システム市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの薬物・遺伝子送達システム市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の薬物・遺伝子送達システム市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの薬物・遺伝子送達システム市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Novartis、Amgen、Oxford BioMedica、SIBIONO、Shanghai Sunway Biotech、Roche、Pfizer、Bayer、Johnson & Johnson、Becton Dickinson、AstraZeneca、Baxter、HSCI、Epeius Biotechnologies
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Drug delivery includes formulations, technologies, methods, and systems used for transferring an active pharmaceutical ingredient into the body as desired, in order to safely accomplish its therapeutic effect. Gene delivery is a procedure employed to introduce foreign DNA into host cells.

Market Analysis and Insights: Global Drug and Gene Delivery Systems Market
The global Drug and Gene Delivery Systems market size is projected to reach US$ 517570 million by 2026, from US$ 496560 million in 2020, at a CAGR of 3.9%% during 2021-2026.

Global Drug and Gene Delivery Systems Scope and Market Size
Drug and Gene Delivery Systems market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug and Gene Delivery Systems market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis
Amgen
Oxford BioMedica
SIBIONO
Shanghai Sunway Biotech
Roche
Pfizer
Bayer
Johnson & Johnson
Becton Dickinson
AstraZeneca
Baxter
HSCI
Epeius Biotechnologies

Market segment by Type, the product can be split into
Drug Delivery Systems
Gene Delivery Systems
Market segment by Application, split into
Infectious Diseases
Oncology
Ophthalmology
Urology
Diabetes
CNS

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Drug and Gene Delivery Systems Revenue
1.4 Market by Type
1.4.1 Global Drug and Gene Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Drug Delivery Systems
1.4.3 Gene Delivery Systems
1.5 Market by Application
1.5.1 Global Drug and Gene Delivery Systems Market Share by Application: 2020 VS 2026
1.5.2 Infectious Diseases
1.5.3 Oncology
1.5.4 Ophthalmology
1.5.5 Urology
1.5.6 Diabetes
1.5.7 CNS
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Drug and Gene Delivery Systems Market Perspective (2015-2026)
2.2 Global Drug and Gene Delivery Systems Growth Trends by Regions
2.2.1 Drug and Gene Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Drug and Gene Delivery Systems Historic Market Share by Regions (2015-2020)
2.2.3 Drug and Gene Delivery Systems Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Drug and Gene Delivery Systems Market Growth Strategy
2.3.6 Primary Interviews with Key Drug and Gene Delivery Systems Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Drug and Gene Delivery Systems Players by Market Size
3.1.1 Global Top Drug and Gene Delivery Systems Players by Revenue (2015-2020)
3.1.2 Global Drug and Gene Delivery Systems Revenue Market Share by Players (2015-2020)
3.1.3 Global Drug and Gene Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Drug and Gene Delivery Systems Market Concentration Ratio
3.2.1 Global Drug and Gene Delivery Systems Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Drug and Gene Delivery Systems Revenue in 2019
3.3 Drug and Gene Delivery Systems Key Players Head office and Area Served
3.4 Key Players Drug and Gene Delivery Systems Product Solution and Service
3.5 Date of Enter into Drug and Gene Delivery Systems Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Drug and Gene Delivery Systems Historic Market Size by Type (2015-2020)
4.2 Global Drug and Gene Delivery Systems Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Drug and Gene Delivery Systems Market Size by Application (2015-2020)
5.2 Global Drug and Gene Delivery Systems Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Drug and Gene Delivery Systems Market Size (2015-2020)
6.2 Drug and Gene Delivery Systems Key Players in North America (2019-2020)
6.3 North America Drug and Gene Delivery Systems Market Size by Type (2015-2020)
6.4 North America Drug and Gene Delivery Systems Market Size by Application (2015-2020)

7 Europe
7.1 Europe Drug and Gene Delivery Systems Market Size (2015-2020)
7.2 Drug and Gene Delivery Systems Key Players in Europe (2019-2020)
7.3 Europe Drug and Gene Delivery Systems Market Size by Type (2015-2020)
7.4 Europe Drug and Gene Delivery Systems Market Size by Application (2015-2020)

8 China
8.1 China Drug and Gene Delivery Systems Market Size (2015-2020)
8.2 Drug and Gene Delivery Systems Key Players in China (2019-2020)
8.3 China Drug and Gene Delivery Systems Market Size by Type (2015-2020)
8.4 China Drug and Gene Delivery Systems Market Size by Application (2015-2020)

9 Japan
9.1 Japan Drug and Gene Delivery Systems Market Size (2015-2020)
9.2 Drug and Gene Delivery Systems Key Players in Japan (2019-2020)
9.3 Japan Drug and Gene Delivery Systems Market Size by Type (2015-2020)
9.4 Japan Drug and Gene Delivery Systems Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Drug and Gene Delivery Systems Market Size (2015-2020)
10.2 Drug and Gene Delivery Systems Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Drug and Gene Delivery Systems Market Size by Type (2015-2020)
10.4 Southeast Asia Drug and Gene Delivery Systems Market Size by Application (2015-2020)

11 India
11.1 India Drug and Gene Delivery Systems Market Size (2015-2020)
11.2 Drug and Gene Delivery Systems Key Players in India (2019-2020)
11.3 India Drug and Gene Delivery Systems Market Size by Type (2015-2020)
11.4 India Drug and Gene Delivery Systems Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Drug and Gene Delivery Systems Market Size (2015-2020)
12.2 Drug and Gene Delivery Systems Key Players in Central & South America (2019-2020)
12.3 Central & South America Drug and Gene Delivery Systems Market Size by Type (2015-2020)
12.4 Central & South America Drug and Gene Delivery Systems Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Drug and Gene Delivery Systems Introduction
13.1.4 Novartis Revenue in Drug and Gene Delivery Systems Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Drug and Gene Delivery Systems Introduction
13.2.4 Amgen Revenue in Drug and Gene Delivery Systems Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Oxford BioMedica
13.3.1 Oxford BioMedica Company Details
13.3.2 Oxford BioMedica Business Overview
13.3.3 Oxford BioMedica Drug and Gene Delivery Systems Introduction
13.3.4 Oxford BioMedica Revenue in Drug and Gene Delivery Systems Business (2015-2020)
13.3.5 Oxford BioMedica Recent Development
13.4 SIBIONO
13.4.1 SIBIONO Company Details
13.4.2 SIBIONO Business Overview
13.4.3 SIBIONO Drug and Gene Delivery Systems Introduction
13.4.4 SIBIONO Revenue in Drug and Gene Delivery Systems Business (2015-2020)
13.4.5 SIBIONO Recent Development
13.5 Shanghai Sunway Biotech
13.5.1 Shanghai Sunway Biotech Company Details
13.5.2 Shanghai Sunway Biotech Business Overview
13.5.3 Shanghai Sunway Biotech Drug and Gene Delivery Systems Introduction
13.5.4 Shanghai Sunway Biotech Revenue in Drug and Gene Delivery Systems Business (2015-2020)
13.5.5 Shanghai Sunway Biotech Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Drug and Gene Delivery Systems Introduction
13.6.4 Roche Revenue in Drug and Gene Delivery Systems Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Drug and Gene Delivery Systems Introduction
13.7.4 Pfizer Revenue in Drug and Gene Delivery Systems Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Bayer
13.8.1 Bayer Company Details
13.8.2 Bayer Business Overview
13.8.3 Bayer Drug and Gene Delivery Systems Introduction
13.8.4 Bayer Revenue in Drug and Gene Delivery Systems Business (2015-2020)
13.8.5 Bayer Recent Development
13.9 Johnson & Johnson
13.9.1 Johnson & Johnson Company Details
13.9.2 Johnson & Johnson Business Overview
13.9.3 Johnson & Johnson Drug and Gene Delivery Systems Introduction
13.9.4 Johnson & Johnson Revenue in Drug and Gene Delivery Systems Business (2015-2020)
13.9.5 Johnson & Johnson Recent Development
13.10 Becton Dickinson
13.10.1 Becton Dickinson Company Details
13.10.2 Becton Dickinson Business Overview
13.10.3 Becton Dickinson Drug and Gene Delivery Systems Introduction
13.10.4 Becton Dickinson Revenue in Drug and Gene Delivery Systems Business (2015-2020)
13.10.5 Becton Dickinson Recent Development
13.11 AstraZeneca
10.11.1 AstraZeneca Company Details
10.11.2 AstraZeneca Business Overview
10.11.3 AstraZeneca Drug and Gene Delivery Systems Introduction
10.11.4 AstraZeneca Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.11.5 AstraZeneca Recent Development
13.12 Baxter
10.12.1 Baxter Company Details
10.12.2 Baxter Business Overview
10.12.3 Baxter Drug and Gene Delivery Systems Introduction
10.12.4 Baxter Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.12.5 Baxter Recent Development
13.13 HSCI
10.13.1 HSCI Company Details
10.13.2 HSCI Business Overview
10.13.3 HSCI Drug and Gene Delivery Systems Introduction
10.13.4 HSCI Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.13.5 HSCI Recent Development
13.14 Epeius Biotechnologies
10.14.1 Epeius Biotechnologies Company Details
10.14.2 Epeius Biotechnologies Business Overview
10.14.3 Epeius Biotechnologies Drug and Gene Delivery Systems Introduction
10.14.4 Epeius Biotechnologies Revenue in Drug and Gene Delivery Systems Business (2015-2020)
10.14.5 Epeius Biotechnologies Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Drug and Gene Delivery Systems Key Market Segments
Table 2. Key Players Covered: Ranking by Drug and Gene Delivery Systems Revenue
Table 3. Ranking of Global Top Drug and Gene Delivery Systems Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Drug and Gene Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Drug Delivery Systems
Table 6. Key Players of Gene Delivery Systems
Table 7. Global Drug and Gene Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Drug and Gene Delivery Systems Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Drug and Gene Delivery Systems Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Drug and Gene Delivery Systems Market Share by Regions (2015-2020)
Table 11. Global Drug and Gene Delivery Systems Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Drug and Gene Delivery Systems Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Drug and Gene Delivery Systems Market Growth Strategy
Table 17. Main Points Interviewed from Key Drug and Gene Delivery Systems Players
Table 18. Global Drug and Gene Delivery Systems Revenue by Players (2015-2020) (Million US$)
Table 19. Global Drug and Gene Delivery Systems Market Share by Players (2015-2020)
Table 20. Global Top Drug and Gene Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug and Gene Delivery Systems as of 2019)
Table 21. Global Drug and Gene Delivery Systems by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Drug and Gene Delivery Systems Product Solution and Service
Table 24. Date of Enter into Drug and Gene Delivery Systems Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Drug and Gene Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 27. Global Drug and Gene Delivery Systems Market Size Share by Type (2015-2020)
Table 28. Global Drug and Gene Delivery Systems Revenue Market Share by Type (2021-2026)
Table 29. Global Drug and Gene Delivery Systems Market Size Share by Application (2015-2020)
Table 30. Global Drug and Gene Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 31. Global Drug and Gene Delivery Systems Market Size Share by Application (2021-2026)
Table 32. North America Key Players Drug and Gene Delivery Systems Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Drug and Gene Delivery Systems Market Share (2019-2020)
Table 34. North America Drug and Gene Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 35. North America Drug and Gene Delivery Systems Market Share by Type (2015-2020)
Table 36. North America Drug and Gene Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 37. North America Drug and Gene Delivery Systems Market Share by Application (2015-2020)
Table 38. Europe Key Players Drug and Gene Delivery Systems Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Drug and Gene Delivery Systems Market Share (2019-2020)
Table 40. Europe Drug and Gene Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Drug and Gene Delivery Systems Market Share by Type (2015-2020)
Table 42. Europe Drug and Gene Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Drug and Gene Delivery Systems Market Share by Application (2015-2020)
Table 44. China Key Players Drug and Gene Delivery Systems Revenue (2019-2020) (Million US$)
Table 45. China Key Players Drug and Gene Delivery Systems Market Share (2019-2020)
Table 46. China Drug and Gene Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 47. China Drug and Gene Delivery Systems Market Share by Type (2015-2020)
Table 48. China Drug and Gene Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 49. China Drug and Gene Delivery Systems Market Share by Application (2015-2020)
Table 50. Japan Key Players Drug and Gene Delivery Systems Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Drug and Gene Delivery Systems Market Share (2019-2020)
Table 52. Japan Drug and Gene Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Drug and Gene Delivery Systems Market Share by Type (2015-2020)
Table 54. Japan Drug and Gene Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Drug and Gene Delivery Systems Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Drug and Gene Delivery Systems Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Drug and Gene Delivery Systems Market Share (2019-2020)
Table 58. Southeast Asia Drug and Gene Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Drug and Gene Delivery Systems Market Share by Type (2015-2020)
Table 60. Southeast Asia Drug and Gene Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Drug and Gene Delivery Systems Market Share by Application (2015-2020)
Table 62. India Key Players Drug and Gene Delivery Systems Revenue (2019-2020) (Million US$)
Table 63. India Key Players Drug and Gene Delivery Systems Market Share (2019-2020)
Table 64. India Drug and Gene Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 65. India Drug and Gene Delivery Systems Market Share by Type (2015-2020)
Table 66. India Drug and Gene Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 67. India Drug and Gene Delivery Systems Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Drug and Gene Delivery Systems Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Drug and Gene Delivery Systems Market Share (2019-2020)
Table 70. Central & South America Drug and Gene Delivery Systems Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Drug and Gene Delivery Systems Market Share by Type (2015-2020)
Table 72. Central & South America Drug and Gene Delivery Systems Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Drug and Gene Delivery Systems Market Share by Application (2015-2020)
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Product
Table 77. Novartis Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 78. Novartis Recent Development
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Product
Table 82. Amgen Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 83. Amgen Recent Development
Table 84. Oxford BioMedica Company Details
Table 85. Oxford BioMedica Business Overview
Table 86. Oxford BioMedica Product
Table 87. Oxford BioMedica Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 88. Oxford BioMedica Recent Development
Table 89. SIBIONO Company Details
Table 90. SIBIONO Business Overview
Table 91. SIBIONO Product
Table 92. SIBIONO Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 93. SIBIONO Recent Development
Table 94. Shanghai Sunway Biotech Company Details
Table 95. Shanghai Sunway Biotech Business Overview
Table 96. Shanghai Sunway Biotech Product
Table 97. Shanghai Sunway Biotech Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 98. Shanghai Sunway Biotech Recent Development
Table 99. Roche Company Details
Table 100. Roche Business Overview
Table 101. Roche Product
Table 102. Roche Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 103. Roche Recent Development
Table 104. Pfizer Company Details
Table 105. Pfizer Business Overview
Table 106. Pfizer Product
Table 107. Pfizer Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 108. Pfizer Recent Development
Table 109. Bayer Business Overview
Table 110. Bayer Product
Table 111. Bayer Company Details
Table 112. Bayer Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 113. Bayer Recent Development
Table 114. Johnson & Johnson Company Details
Table 115. Johnson & Johnson Business Overview
Table 116. Johnson & Johnson Product
Table 117. Johnson & Johnson Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 118. Johnson & Johnson Recent Development
Table 119. Becton Dickinson Company Details
Table 120. Becton Dickinson Business Overview
Table 121. Becton Dickinson Product
Table 122. Becton Dickinson Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 123. Becton Dickinson Recent Development
Table 124. AstraZeneca Company Details
Table 125. AstraZeneca Business Overview
Table 126. AstraZeneca Product
Table 127. AstraZeneca Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 128. AstraZeneca Recent Development
Table 129. Baxter Company Details
Table 130. Baxter Business Overview
Table 131. Baxter Product
Table 132. Baxter Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 133. Baxter Recent Development
Table 134. HSCI Company Details
Table 135. HSCI Business Overview
Table 136. HSCI Product
Table 137. HSCI Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 138. HSCI Recent Development
Table 139. Epeius Biotechnologies Company Details
Table 140. Epeius Biotechnologies Business Overview
Table 141. Epeius Biotechnologies Product
Table 142. Epeius Biotechnologies Revenue in Drug and Gene Delivery Systems Business (2015-2020) (Million US$)
Table 143. Epeius Biotechnologies Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug and Gene Delivery Systems Market Share by Type: 2020 VS 2026
Figure 2. Drug Delivery Systems Features
Figure 3. Gene Delivery Systems Features
Figure 4. Global Drug and Gene Delivery Systems Market Share by Application: 2020 VS 2026
Figure 5. Infectious Diseases Case Studies
Figure 6. Oncology Case Studies
Figure 7. Ophthalmology Case Studies
Figure 8. Urology Case Studies
Figure 9. Diabetes Case Studies
Figure 10. CNS Case Studies
Figure 11. Drug and Gene Delivery Systems Report Years Considered
Figure 12. Global Drug and Gene Delivery Systems Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Drug and Gene Delivery Systems Market Share by Regions: 2020 VS 2026
Figure 14. Global Drug and Gene Delivery Systems Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Drug and Gene Delivery Systems Market Share by Players in 2019
Figure 17. Global Top Drug and Gene Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug and Gene Delivery Systems as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Drug and Gene Delivery Systems Revenue in 2019
Figure 19. North America Drug and Gene Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Drug and Gene Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Drug and Gene Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Drug and Gene Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Drug and Gene Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Drug and Gene Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Drug and Gene Delivery Systems Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed


【掲載企業】

Novartis、Amgen、Oxford BioMedica、SIBIONO、Shanghai Sunway Biotech、Roche、Pfizer、Bayer、Johnson & Johnson、Becton Dickinson、AstraZeneca、Baxter、HSCI、Epeius Biotechnologies

★調査レポート[世界の薬物・遺伝子送達システム市場インサイト及び予測(~2026年)] (コード:QYR20NV11714)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の薬物・遺伝子送達システム市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆